Market Overview:
The global plasma cell neoplasm treatment market is expected to grow at a CAGR of 7.8% from 2018 to 2030. The growth in the market can be attributed to factors such as rising incidence of plasma cell neoplasms, increasing demand for better and advanced therapies, and growing awareness about plasma cell neoplasms. However, the high cost of treatment is expected to restrain the growth of the market during the forecast period. Based on type, radiation therapy is expected to account for the largest share of the global market in 2018. This can be attributed to its advantages such as minimal side effects and short treatment duration as compared to other therapies. Based on application, hospitals are expected to account for the largest share of the global market in 2018.
Product Definition:
A plasma cell neoplasm is a type of cancer that starts in cells called plasma cells. Plasma cells are white blood cells that help fight infection. Most plasma cell neoplasms are slow-growing and not very aggressive. However, some can spread quickly to other parts of the body (metastasize).
Radiation Therapy:
Plasma cell neoplasm (PCN) is a rare disorder affecting less than 4,000 patients in the U.S. annually and has a prevalence of approximately 1 per million in the U.S., Europe, and Japan combined according to data published by the National Cancer Institute (NCI).
Chemotherapy:
Chemotherapy is the use of drugs or chemical substances to treat cancer. The most common types of cancers that are treated with chemotherapy include breast cancer, lung cancer, prostate cancer, and blood cell cancers such as lymphoma and leukemia.
Application Insights:
The hospitals application segment dominated the market for global plasma cell neoplasm treatment and accounted for a revenue share of more than 60.0% in 2017. The hospital-based setting is considered to be the most effective method of delivering cancer therapies due to its combination of advantages, such as close monitoring by a multidisciplinary team, introduction of new technologies such as proton therapy and radionuclide therapy, and an increase in research activities that focus on improving patient outcomes.
However, specialty clinics are expected to witness lucrative growth over the forecast period owing to their ability to treat patients with less invasive procedures; increased availability of advanced treatments; rising demand for minimally invasive procedures due to technological advancements; increasing awareness about these centers among patients; favorable government initiatives related cancer control & screening programs coupled with high adoption rate among geriatric population suffering from blood disorders or bone metastasis who require regular checkups at outpatient facilities.
Regional Analysis:
North America dominated the global market in 2017. This can be attributed to the presence of a large number of industry players, high adoption rate for advanced treatment options, and favorable reimbursement scenario. Moreover, increasing R&D investments by companies is expected to drive growth during the forecast period.
Asia Pacific is estimated to witness lucrative growth over the next eight years owing to rising healthcare expenditure levels and improving healthcare infrastructure in countries such as China and India. Furthermore, growing awareness about plasma cell neoplasms among patients coupled with an increase in spending power are factors anticipated to boost revenue generation from this region during the forecast period.
Growth Factors:
- Increasing incidence of plasma cell neoplasm
- Rising demand for better treatment options for plasma cell neoplasm
- Technological advancements in the field of plasma cell neoplasm treatment
- Growing awareness about plasma cell neoplasms and their treatments
- Availability of government funding for research on plasma cell neoplasms
Scope Of The Report
Report Attributes
Report Details
Report Title
Plasma Cell Neoplasm Treatment Market Research Report
By Type
Radiation Therapy, Chemotherapy, Biologics or Targeted Therapy
By Application
Hospitals, Specialty Clinics, Ambulatory Surgical Centers
By Companies
AbbVie, Amgen, Bristol-Myers Squibb, Celgene, Janssen Biotech, Millennium Pharmaceutical, Novartis, Spectrum Pharmaceutical, Sun Pharmaceutical Industries
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
240
Number of Tables & Figures
168
Customization Available
Yes, the report can be customized as per your need.
Global Plasma Cell Neoplasm Treatment Market Report Segments:
The global Plasma Cell Neoplasm Treatment market is segmented on the basis of:
Types
Radiation Therapy, Chemotherapy, Biologics or Targeted Therapy
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospitals, Specialty Clinics, Ambulatory Surgical Centers
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- AbbVie
- Amgen
- Bristol-Myers Squibb
- Celgene
- Janssen Biotech
- Millennium Pharmaceutical
- Novartis
- Spectrum Pharmaceutical
- Sun Pharmaceutical Industries
Highlights of The Plasma Cell Neoplasm Treatment Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Radiation Therapy
- Chemotherapy
- Biologics or Targeted Therapy
- By Application:
- Hospitals
- Specialty Clinics
- Ambulatory Surgical Centers
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Plasma Cell Neoplasm Treatment Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Plasma cell neoplasm treatment is a type of cancer treatment that uses plasma cells to fight the cancer. Plasma cells are white blood cells that help the body fight infections. When plasma cells become tumors, they can no longer do their job and can cause serious health problems. Treatment using plasma cells to attack the tumor is known as plasmapheresis.
Some of the major players in the plasma cell neoplasm treatment market are AbbVie, Amgen, Bristol-Myers Squibb, Celgene, Janssen Biotech, Millennium Pharmaceutical, Novartis, Spectrum Pharmaceutical, Sun Pharmaceutical Industries.
The plasma cell neoplasm treatment market is expected to grow at a compound annual growth rate of 7.8%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Plasma Cell Neoplasm Treatment Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Plasma Cell Neoplasm Treatment Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Plasma Cell Neoplasm Treatment Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Plasma Cell Neoplasm Treatment Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Plasma Cell Neoplasm Treatment Market Size & Forecast, 2020-2028
4.5.1 Plasma Cell Neoplasm Treatment Market Size and Y-o-Y Growth
4.5.2 Plasma Cell Neoplasm Treatment Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 Radiation Therapy
5.2.2 Chemotherapy
5.2.3 Biologics or Targeted Therapy
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Hospitals
6.2.2 Specialty Clinics
6.2.3 Ambulatory Surgical Centers
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Plasma Cell Neoplasm Treatment Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Plasma Cell Neoplasm Treatment Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 Radiation Therapy
9.6.2 Chemotherapy
9.6.3 Biologics or Targeted Therapy
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Hospitals
9.10.2 Specialty Clinics
9.10.3 Ambulatory Surgical Centers
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 Radiation Therapy
10.6.2 Chemotherapy
10.6.3 Biologics or Targeted Therapy
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Hospitals
10.10.2 Specialty Clinics
10.10.3 Ambulatory Surgical Centers
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 Radiation Therapy
11.6.2 Chemotherapy
11.6.3 Biologics or Targeted Therapy
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Hospitals
11.10.2 Specialty Clinics
11.10.3 Ambulatory Surgical Centers
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 Radiation Therapy
12.6.2 Chemotherapy
12.6.3 Biologics or Targeted Therapy
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Hospitals
12.10.2 Specialty Clinics
12.10.3 Ambulatory Surgical Centers
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 Radiation Therapy
13.6.2 Chemotherapy
13.6.3 Biologics or Targeted Therapy
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Hospitals
13.10.2 Specialty Clinics
13.10.3 Ambulatory Surgical Centers
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Plasma Cell Neoplasm Treatment Market: Competitive Dashboard
14.2 Global Plasma Cell Neoplasm Treatment Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 AbbVie
14.3.2 Amgen
14.3.3 Bristol-Myers Squibb
14.3.4 Celgene
14.3.5 Janssen Biotech
14.3.6 Millennium Pharmaceutical
14.3.7 Novartis
14.3.8 Spectrum Pharmaceutical
14.3.9 Sun Pharmaceutical Industries
